Broker Call Lifts Qurient, AbClon, L&C Bio Rebounds on Rights Offering[K-Bio Pulse]
- created on 08/05/2026 6:00:14 AM
- modified on 08/05/2026 6:00:14 AM
This article was released as Pharm Edaily Premium Content on 08/05/2026 6:00:14 AM
Subscribe
Unauthorized reproduction or distribution is illegal and subject to criminal penalties.
Pharm Edaily enforces a zero-tolerance policy and will take strict action.
Pharm Edaily enforces a zero-tolerance policy and will take strict action.
Premium Content
이 기사는 유료 구독자를 위한 프리미엄 콘텐츠입니다.
유료 구독(플래티넘)을 통해 더 많은 콘텐츠를 만나보세요.
This article is premium content for paid subscribers.
Subscribe to paid subscription (Platinum) for full access.
저작권자 © 팜이데일리 - 기사 무단전재, 재배포시 법적인 처벌을 받을 수 있습니다.
![Broker Call Lifts Qurient, AbClon, L&C Bio Rebounds on Rights Offering[K-Bio Pulse]](https://image.edaily.co.kr/images/Photo/files/NP/S/2026/08/PS26080500184b.jpg)
![딥노이드·펩트론 上…엘앤씨바이오는 유상증자에 약세[바이오맥짚기]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/08/PS26080400430b.jpg)
![리포트 한 장에 20% 급등...큐리언트·앱클론 날고, 엘앤씨바이오는 유증 재평가[바이오맥짚기]](https://image.edaily.co.kr/images/Photo/files/NP/S/2026/08/PS26080500182b.jpg)
!["모두가 망할 거라 했습니다" 구글·애플·MS가 '유일한 파트너'로 찍은 한국 스타트업 DOT [바이오스터디]](https://i.ytimg.com/vi/yTUyAxrWvdc/mqdefault.jpg)
SPOTLIGHT
